{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:05:10Z","timestamp":1793106310003,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ebiom.2021.103453","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T02:12:06Z","timestamp":1624068726000},"page":"103453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma"],"prefix":"10.1016","volume":"69","author":[{"given":"Gabrielle","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Bouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1975-4665","authenticated-orcid":false,"given":"Dolores","family":"Hambardzumyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos G.","family":"Hadjipanayis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2021.103453_bib0001","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/neuonc\/nov057","article-title":"A pilot study using carboplatin, vincristine, and temozolomide in children with progressive\/symptomatic low-grade glioma: a children's oncology group study\u2020","volume":"17","author":"Chintagumpala","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0002","article-title":"CBTRUS statistical Report: primary brain and central nervous system tumors diagnosed in the United States","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103453_bib0003","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103453_bib0004","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"19","key":"10.1016\/j.ebiom.2021.103453_bib0005","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for pediatric oncology DIPG registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103453_bib0006","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2021.103453_bib0007","doi-asserted-by":"crossref","unstructured":"Valvi S, Gottardo NG. Diffuse intrinsic pontine glioma. In: Brain tumors - An update. InTech; 2018. https:\/\/doi.org\/10.5772\/intechopen.78578.","DOI":"10.5772\/intechopen.78578"},{"key":"10.1016\/j.ebiom.2021.103453_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1570159X14666160509123229","article-title":"Current neuropharmacology send orders for reprints to reprints@benthamscience.ae diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets","volume":"15","author":"Johung","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103453_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8110200","article-title":"Intersection of brain development and pediatric diffuse midline gliomas: potential role of microenvironment in tumor growth","volume":"8","author":"Loveson","year":"2018","journal-title":"Brain Sci"},{"key":"10.1016\/j.ebiom.2021.103453_bib0011","doi-asserted-by":"crossref","unstructured":"Nagaraja S, Vitanza NA, Woo P, et\u00a0al. Transcriptional dependencies in Diffuse Intrinsic Pontine Glioma Graphical abstract HHS Public Access. doi:10.1016\/j.ccell.2017.03.011","DOI":"10.1016\/j.ccell.2017.03.011"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cne.23690","article-title":"Postnatal growth of the human pons: a morphometric and immunohistochemical analysis","volume":"523","author":"Tate","year":"2015","journal-title":"J Comp Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103453_bib0013","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0b013e318294e817","article-title":"Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas","volume":"37","author":"Ballester","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"6386","key":"10.1016\/j.ebiom.2021.103453_bib0014","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"issue":"7384","key":"10.1016\/j.ebiom.2021.103453_bib0016","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodeling genes in pediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0017","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0018","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"6134","key":"10.1016\/j.ebiom.2021.103453_bib0019","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.1232245","article-title":"Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma","volume":"340","author":"Lewis","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bpa.12042","article-title":"Evaluation of Histone 3 Lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas","volume":"23","author":"Venneti","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0021","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"Larson","year":"2019","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.ebiom.2021.103453_bib0022","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1158\/0008-5472.CAN-14-1298","article-title":"ACVR1 mutations in DIPG: lessons learned from FOP","volume":"74","author":"Taylor","year":"2014","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103453_bib0023","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajhg.2017.02.005","article-title":"De novo truncating mutations in the last and penultimate exons of PPM1D cause an intellectual disability syndrome","volume":"100","author":"Jansen","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103453_bib0024","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/dvdy.21021","article-title":"BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesis","volume":"236","author":"Komatsu","year":"2007","journal-title":"Dev Dyn"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103453_bib0026","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ng.2995","article-title":"Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103453_bib0027","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00109-017-1536-2","article-title":"WIP1 phosphatase as pharmacological target in cancer therapy","volume":"95","author":"Pech\u00e1\u010dkov\u00e1","year":"2017","journal-title":"J Mol Med"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103453_bib0028","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor \u03b1 and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J Clin Oncol"},{"issue":"38","key":"10.1016\/j.ebiom.2021.103453_bib0029","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.stem.2009.05.026","article-title":"Cdk4\/CyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors","volume":"5","author":"Lange","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ebiom.2021.103453_bib0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ebiom.2019.04.043","article-title":"Potent anti-tumor efficacy of palbociclib in treatment-na\u00efve H3.3K27M-mutant diffuse intrinsic pontine glioma","volume":"43","author":"Sun","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2021.103453_bib0032","doi-asserted-by":"crossref","unstructured":"Funato K, Major T, Lewis PW, Allis CD, Tabar V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science (80-). 2014;346(6216):1529\u201333. doi:10.1126\/science.1253799","DOI":"10.1126\/science.1253799"},{"issue":"43","key":"10.1016\/j.ebiom.2021.103453_bib0033","first-page":"1","article-title":"Natural killer cells in the brain tumor microenvironment: defining a new era in neuro-oncology","volume":"10","author":"Fares","year":"2019","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.ebiom.2021.103453_bib0034","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00381-020-04665-9","article-title":"Decreased natural killer cells in diffuse intrinsic pontine glioma patients","author":"Zhang","year":"2020","journal-title":"Child's Nerv Syst"},{"issue":"19","key":"10.1016\/j.ebiom.2021.103453_bib0035","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1073\/pnas.1715295115","article-title":"Complex role of NK cells in regulation of oncolytic virus\u2013bortezomib therapy","volume":"115","author":"Kim","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/neuonc\/noy145","article-title":"Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy","volume":"21","author":"Lieberman","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0037","first-page":"1","article-title":"Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma","author":"Bailey","year":"2020","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0038","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.0303114","article-title":"Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification","volume":"75","author":"Guillemin","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103453_bib0039","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/dneu.22545","article-title":"Development and maintenance of the brain's immune toolkit: microglia and non-parenchymal brain macrophages","volume":"78","author":"Lopez-Atalaya","year":"2018","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0040","series-title":"Platelet-Derived growth factor beta is a potent inflammatory driver in pediatric High- Grade Glioma","author":"Ross","year":"2020"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0041","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab Investig"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0042","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Lin","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"7390","key":"10.1016\/j.ebiom.2021.103453_bib0043","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","article-title":"IDH mutation impairs histone demethylation and results in a block to cell differentiation","volume":"483","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103453_bib0044","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.21142","article-title":"Genetic modeling of gliomas in mice: new tools to tackle old problems","volume":"59","author":"Hambardzumyan","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.ebiom.2021.103453_bib0045","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3389\/fonc.2019.01418","article-title":"Patient-derived orthotopic xenograft models of pediatric brain tumors: in a mature phase or still in its infancy?","volume":"9","author":"Hermans","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0046","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.25224","article-title":"BRIEF REPORT Diffuse intrinsic pontine glioma biopsy: a single institution experience","volume":"62","author":"Wang","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"1 SUPPL","key":"10.1016\/j.ebiom.2021.103453_bib0047","first-page":"1","article-title":"Stereotactic biopsy of diffuse pontine lesions in children","volume":"107","author":"Roujeau","year":"2007","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2019.9.FOCUS19745","article-title":"Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care","volume":"48","author":"Williams","year":"2020","journal-title":"Neurosurg Focus"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103453_bib0049","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1750-3639.2010.00468.x","article-title":"Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model","volume":"21","author":"Caretti","year":"2011","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11060-011-0796-x","article-title":"An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing","volume":"108","author":"Aoki","year":"2012","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103453_bib0051","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/neuonc\/nou330","article-title":"Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma","volume":"17","author":"Truffaux","year":"2015","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0052","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/neuonc\/not220","article-title":"Targeting wee1 for the treatment of pediatric high-grade gliomas","volume":"16","author":"Mueller","year":"2014","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103453_bib0053","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev"},{"issue":"32","key":"10.1016\/j.ebiom.2021.103453_bib0054","doi-asserted-by":"crossref","first-page":"52543","DOI":"10.18632\/oncotarget.15002","article-title":"New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis","volume":"8","author":"Plessier","year":"2017","journal-title":"Oncotarget"},{"issue":"FEB","key":"10.1016\/j.ebiom.2021.103453_bib0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fonc.2019.00092","article-title":"Current murine models and new developments in H3K27M diffuse midline gliomas","volume":"9","author":"Welby","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0056","doi-asserted-by":"crossref","first-page":"e16375","DOI":"10.1371\/journal.pone.0016375","article-title":"Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors","volume":"6","author":"Thirant","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0057","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","article-title":"Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment","volume":"110","author":"Hashizume","year":"2012","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103453_bib0058","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally-defined therapeutic targets in diffuse intrinsic pontine glioma: a report of the children's oncology group DIPG Preclinical consortium HHS public access","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103453_bib0059","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/0008-5472.CAN-09-2503","article-title":"Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma","volume":"70","author":"Becher","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103453_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1593\/tlo.09100","article-title":"Modeling adult gliomas using RCAS\/t-va technology","volume":"2","author":"Hambardzumyan","year":"2009","journal-title":"Transl Oncol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103453_bib0061","doi-asserted-by":"crossref","first-page":"e77639","DOI":"10.1371\/journal.pone.0077639","article-title":"PD-0332991, a CDK4\/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma","volume":"8","author":"Barton","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169485","article-title":"Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models. Castro MG","volume":"12","author":"Hennika","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2021.103453_bib0063","doi-asserted-by":"crossref","unstructured":"Tosi U, Kommidi H, Adeuyan O, et\u00a0al. PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models.; 2020. http:\/\/advances.sciencemag.org\/. Accessed September 26, 2020.","DOI":"10.1126\/sciadv.abb4105"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0064","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neo.2015.12.002","article-title":"A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells","volume":"18","author":"Misuraca","year":"2016","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","article-title":"Role of radiation therapy in the management of diffuse intrinsic pontine glioma: a systematic review","volume":"4","author":"Gallitto","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0066","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.ijrobp.2012.09.004","article-title":"Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study","volume":"85","author":"Bradley","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103453_bib0067","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/1097-0142(19820315)49:6<1294::AID-CNCR2820490636>3.0.CO;2-V","article-title":"Brain stem gliomas: an autopsy study of 25 cases","volume":"49","author":"Mantravadi","year":"1982","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103453_bib0068","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0360-3016(85)90244-5","article-title":"Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy","volume":"11","author":"Halperin","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103453_bib0069","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(93)90228-N","article-title":"Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a pediatric oncology group study","volume":"27","author":"Freeman","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ebiom.2021.103453_bib0070","doi-asserted-by":"crossref","unstructured":"Rita A, Antunes P, Scheyltjens I, et\u00a0al. Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies. doi:10.7554\/eLife.52176","DOI":"10.7554\/eLife.52176"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103453_bib0071","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/brain\/awl173","article-title":"Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-\u03b2-dependent HIF-1\u03b1-mediated induction of CXCL12","volume":"129","author":"Tabatabai","year":"2006","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0072","doi-asserted-by":"crossref","DOI":"10.1172\/JCI40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2021.103453_bib0073","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/bjc.2011.169","article-title":"Targeting SDF-1&sol;CXCR4 to inhibit tumour vasculature for treatment of glioblastomas","volume":"104","author":"Tseng","year":"2011","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103453_bib0074","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3892\/or.2014.3536","article-title":"Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer","volume":"32","author":"Liu","year":"2014","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/bjc.2013.830","article-title":"Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats","volume":"110","author":"Walters","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2021.103453_bib0076","article-title":"PD-1\/PD-L1 based combinational cancer therapy: icing on the cake","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"328","key":"10.1016\/j.ebiom.2021.103453_bib0077","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2021.103453_bib0078","first-page":"63","author":"Jalali","year":"2015"},{"issue":"370","key":"10.1016\/j.ebiom.2021.103453_bib0079","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2942","article-title":"Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM","volume":"8","author":"Mathios","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103453_bib0080","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","article-title":"Temozolomide for immunomodulation in the treatment of glioblastoma","volume":"20","author":"Karachi","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0081","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/neuonc\/noq157","article-title":"Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma","volume":"13","author":"Sampson","year":"2011","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103453_bib0082","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1078-0432.CCR-16-2057","article-title":"Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination","volume":"23","author":"Batich","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059082","article-title":"Myeloablative temozolomide enhances CD8+ T-cell responses to vaccine and is required for efficacy against brain tumors in mice","volume":"8","author":"Sanchez-Perez","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103453_bib0084","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.celrep.2018.11.014","article-title":"Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis","volume":"25","author":"Osorio","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2021.103453_bib0085","article-title":"Antitumour treatment diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology","author":"Jansen","year":"2011","journal-title":"CANCER Treat Rev"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103453_bib0086","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the children's oncology group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103453_bib0087","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","article-title":"Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"106","author":"Chassot","year":"2012","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0088","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-019-03287-9","article-title":"Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?","volume":"145","author":"El-Khouly","year":"2019","journal-title":"J Neurooncol"},{"issue":"OCT","key":"10.1016\/j.ebiom.2021.103453_bib0089","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fonc.2017.00254","article-title":"Effective drug delivery in diffuse intrinsic pontine glioma: a theoretical model to identify potential candidates","volume":"7","author":"El-Khouly","year":"2017","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103453_bib0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J Mol Med"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0091","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00401-014-1274-2","article-title":"CNS macrophages and peripheral myeloid cells in brain tumors","volume":"128","author":"Glass","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0092","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3389\/fimmu.2020.01402","article-title":"Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma","volume":"11","author":"DeCordova","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103453_bib0093","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J Immunol"},{"issue":"20","key":"10.1016\/j.ebiom.2021.103453_bib0094","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1158\/0008-5472.CAN-13-1491","article-title":"Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas","volume":"73","author":"Paugh","year":"2013","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103453_bib0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0096","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ygyno.2006.05.045","article-title":"Stromal cell-derived factor 1\u03b1 stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1\/2 and Akt","volume":"103","author":"Zhao","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103453_bib0097","first-page":"3833","article-title":"The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases","volume":"63","author":"Zeelenberg","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0098","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-05-1376","article-title":"CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications","volume":"12","author":"Airoldi","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103453_bib0099","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/pin.12438","article-title":"Peptide vaccination therapy: towards the next generation","volume":"66","author":"Tsukahara","year":"2016","journal-title":"Pathol Int"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103453_bib0100","first-page":"1","article-title":"K27M-mutant histone-3 as a novel target for glioma immunotherapy","volume":"6","author":"Ochs","year":"2017","journal-title":"Oncoimmunology"},{"issue":"APR","key":"10.1016\/j.ebiom.2021.103453_bib0101","first-page":"1","article-title":"Immune response generated with the administration of autologous dendritic cells pulsed with an allogenic tumoral cell-lines lysate in patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"8","author":"Benitez-Ribas","year":"2018","journal-title":"Front Oncol"},{"issue":"JAN","key":"10.1016\/j.ebiom.2021.103453_bib0102","first-page":"1","article-title":"Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines","volume":"6","author":"Vandenberk","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0103","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/medicines7050029","article-title":"Addition of multimodal immunotherapy to combination treatment strategies for children with DIPG: a single institution experience","volume":"7","author":"Van Gool","year":"2020","journal-title":"Medicines"},{"key":"10.1016\/j.ebiom.2021.103453_bib0105","series-title":"Ad-CD40L mobilizes CD4 t cells for the treatment of brainstem tumors","author":"Wongthida","year":"2020"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103453_bib0106","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-18-0432","article-title":"CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors","volume":"25","author":"Majzner","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0107","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas letter","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0108","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-018-2991-5","article-title":"Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience","volume":"140","author":"Kline","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103453_bib0109","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11060-017-2643-1","article-title":"Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma","volume":"136","author":"Fried","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ebiom.2021.103453_bib0110","first-page":"awab155","article-title":"Tumor immune landscape of pediatric high-grade gliomas.[published online ahead of print, 2021 Apr 15]","author":"Ross","year":"2021","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0111","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/cercor\/bhv001","article-title":"The brain basis of positive and negative affect: evidence from a meta-analysis of the human neuroimaging literature","volume":"26","author":"Lindquist","year":"2016","journal-title":"Cereb Cortex"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103453_bib0112","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103453_bib0113","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","article-title":"H3.3K27M cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas","volume":"32","author":"Pathania","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103453_bib0114","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1172\/JCI133310","article-title":"Everolimus improves the efficacy of dasatinib in PDGFR\u03b1-driven glioma","volume":"130","author":"Miklja","year":"2020","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0115","first-page":"381","article-title":"Generation of diffuse intrinsic pontine glioma mouse models by brainstem targeted in utero electroporation","volume":"22","author":"Patel","year":"2019","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103453_bib0116","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ccell.2020.02.002","article-title":"Mutant ACVR1 Arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas","volume":"37","author":"Fortin","year":"2020","journal-title":"Cancer Cell"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421002462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421002462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:06:24Z","timestamp":1762455984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421002462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":116,"alternative-id":["S2352396421002462"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103453","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103453"}}